Background: A new definition for complicated coagulase-negative staphylococcal (CoNS) bacteremia was recently proposed. The aim of this study was to identify predictors of mortality in patients with CoNS bacteremia and evaluate the proposed definition of complicated bacteremia.
Methods: This retrospective study was conducted at the Lausanne University Hospital, Switzerland (2015-23) and included adult patients with CoNS bacteremia.
Results: During the study period, 326 episodes of CoNS bacteremia were included, with 250 (77%) episodes involving Staphylococcus epidermidis. Most infections were catheter-related bacteremias (233 episodes; 68%). Based on the proposed definition, 195 (60%) episodes had complicated disease. The overall 30-day mortality was 9% (29 episodes). Infectious diseases (ID) consultation was provided within 48h from bacteremia onset in 285/326 (87%) episodes. Source control was deemed necessary in 275 (84%) episodes and was performed within 48h in 167/275 (61%) episodes. No difference on 30-day mortality was observed among complicated and uncomplicated disease (10% versus 7%; P=0.327). The Cox multivariable regression model showed that a Charlson comorbidity index >4 (aHR 3.80, 95% CI 1.52-9.47) was associated with 30-day mortality, while ID consultation within 48h (0.22, 0.10-0.48), and performance of source control interventions within 48h (0.12, 0.03-0.50) were associated with improved outcome. Complicated disease was not associated with 30-day mortality (0.39, 0.10-1.46).
Conclusions: The proposed definition for complicated CoNS bacteremia failed to identify patients at higher risk for mortality in our cohort. Our findings highlight the importance of ID consultation in guiding antimicrobial treatment and recommending source control interventions for patients with CoNS bacteremia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/cid/ciaf119 | DOI Listing |
Clin Infect Dis
March 2025
Infectious Diseases Service, Lausanne University Hospital, Lausanne, Switzerland.
Background: A new definition for complicated coagulase-negative staphylococcal (CoNS) bacteremia was recently proposed. The aim of this study was to identify predictors of mortality in patients with CoNS bacteremia and evaluate the proposed definition of complicated bacteremia.
Methods: This retrospective study was conducted at the Lausanne University Hospital, Switzerland (2015-23) and included adult patients with CoNS bacteremia.
Ann Clin Microbiol Antimicrob
February 2025
Department of Medical Microbiology, Orotta College of Medicine and Health Sciences, Asmara, Eritrea.
Background: An important knowledge gap exists on the epidemiology of blood stream infections (BSIs) in low-middle-income countries (LMICs). In this retrospective analysis, we evaluated the etiology, antimicrobial resistance (AMR) and trends of BSIs in Eritrea.
Methods: The study reviewed 9-year records (January 2014- December 2022) of 3153 patients with blood culture results available in the National Health Laboratory (NHL) archives.
Am J Infect Control
February 2025
Department of Medicine, Brooke Army Medical Center, Joint Base San Antonio, Fort Sam Houston, TX; Department Medicine, Uniformed Services University, Bethesda, MD.
Background: Coagulase-negative Staphylococci (CoNS) are frequently cited as the most common cause of bacteremia in patients receiving extracorporeal membrane oxygenation (ECMO), yet there is significant variability in reporting rates between centers.
Methods: All patients who received ECMO with CoNS isolated from blood cultures between January 2022 and March 2024 were included in this retrospective cohort study. Previously reported bacteremia definitions were applied to determine the variability in rates by definition.
J Pediatr Pharmacol Ther
February 2025
Department of Pharmacy (R-YC, BAH, HT, MAD), Department of Pediatrics, Division of Infectious Diseases (RC, NAN), UC Davis Children's Hospital, Sacramento, CA.
Objective: To review pediatric data on vancomycin exposure threshold against methicillin-resistant (MRSA) and coagulase-negative staphylococci (MR-CoNS).
Methods: A systematic review was conducted through July 2023. Publications in English that explored vancomycin effectiveness threshold against MRSA, CoNS, or in pediatrics were eligible.
Expert Rev Mol Diagn
March 2025
Hebei Provincial Center for Clinical Laboratories, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Introduction: Rapid and accurate laboratory diagnosis is essential for the effective treatment of bloodstream infection (BSI).
Areas Covered: This review aims to address novel and traditional approaches that exhibit different performance characteristics in the diagnosis of BSI. In particular, the authors will discuss the pros and cons of the blood culture-based phenotypic methods, nucleic acid-targeted molecular methods, and host response-targeted biomarker detection in the diagnosis of BSI.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!